Adam D. Cohen

3 ta ish

University of Pennsylvania

1. Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

   Jesús G. Berdeja, Deepu Madduri, Saad Z. Usmani +33

   Maqola20214 iqtibos

   ABIABI:AkademIndex/2026.other.475845

2. CRISPR-engineered T cells in patients with refractory cancer

   Edward A. Stadtmauer, Joseph A. Fraietta, Megan M. Davis +38

   MaqolaOAOchiq kirish20203 iqtibos

   ABIABI:AkademIndex/2026.other.102870

3. How to Train Your T Cells: Overcoming Immune Dysfunction in Multiple Myeloma

   Adam D. Cohen, Noopur Raje, Jessica Fowler +3

   Sharh maqola20192 iqtibos

   ABIABI:AkademIndex/2026.other.296857